Purpose:

EMERGENCY MEDICAL SERVICES AGENCY
TITLE: MONITORING AN INFUSION WITH POTASSIUM CHLORIDE
EMS Policy No. 5952
PURPOSE: The purpose of this policy is to provide a mechanism for paramedics to be permitted to monitor infusions of Potassium Chloride (KCL) during interfacility transfers. AUTHORITY: Health and Safety Code, Division 2.5, Sections 1797.220 POLICY: I. All ALS Ambulance providers approved by the San Joaquin County EMS Agency Medical Director will be permitted to provide the service of monitoring potassium chloride infusions during interfacility transports from approved hospital(s) within their service area. Only those paramedics who have successfully completed training program(s) approved by the San Joaquin County EMS Agency Medical Director on potassium chloride infusions will be permitted to monitor them during interfacility transports. Patients that are candidates for paramedic transport will have preexisting KCL infusions in peripheral lines. Prehospital care providers are not allowed to start or add KCL to the I.V. solution. Infusions containing KCL In accordance with the provisions of this policy, a paramedic may transport a patient who has a preexisting I.V. solution containing KCL only when following these parameters: Signed transfer orders from the transferring physician must be obtained prior to transport. Infusions containing KCL may be monitored only. Patient is placed on cardiac and pulse oximetry monitors and monitored continuously during transport. KCL infusion concentration will not exceed 20 mEq/liter administered at a mechanically controlled rate not to exceed 10 mEq/hour. If fluid bolus or I.V. medications are needed, the KCL infusion shall be discontinued and a new I.V. solution without KCL and administration device shall be used as replacement. DO NOT BOLUS FLUIDS CONTAINING KCL. Vital signs will be monitored and documented no less than every 10 JANUARY 1, 2007
EMERGENCY MEDICAL SERVICES AGENCY
TITLE: MONITORING AN INFUSION WITH POTASSIUM CHLORIDE
EMS Policy No. 5952
Monitor patient for adverse affects during transport including: 1. Cardiovascular: dysrhythmias, cardiac arrest Gastrointestinal: nausea/vomiting, diarrhea, abdominal pain Neurological: paresthesia of extremities, muscular paralysis, confusion I.V. infiltration: monitor I.V. site as infiltration may cause necrosis. If patient complains of burning or irritation at the insertion site, the I.V. should be checked for patency and the infusion rate slowed or discontinued. General Information on Potassium Chloride Potassium is an essential macromineral in human nutrition with a wide range of biochemical and physiological roles. Among other things, it is important in the transmission of nerve impulses, the contraction of cardiac, skeletal and smooth muscle, the production of energy, the synthesis of nucleic acids, the maintenance of intracellular tonicity and the maintenance of normal blood pressure. Indications for the use of Potassium Chloride The treatment of potassium depletion in patients with hypokalemia Treatment of digitalis intoxication.
Renal impairment with oliguria or azotemia Extensive tissue breakdown as in severe burns Any other condition which impairs potassium excretion Potassium should be used with caution in diseases associated with JANUARY 1, 2007
EMERGENCY MEDICAL SERVICES AGENCY
TITLE: INTRAVENOUS INFUSION WITH POTASSIUM CHLORIDE
EMS Policy No. 5952
Venous Thrombosis, Infection at injection site 4. Hypervolemia 5. Hyperkalemia 6. Abdominal Cardiac arrest can occur with high potassium conditions, such as chronic renal failure, burns, acidosis, dehydration, and potassium sparing diuretic usage. Drug interactions causing elevation of potassium can occur with ACE inhibitors (used to treat high blood pressure) and certain diuretics (aldactone and triamterene). Standard Dosages for Potassium Chloride Infusions: 1. For serum potassium level > 2.5mEq/L a. Continuous IV Infusion: 10mEq/hour in a concentration up to 40mEq/L. Max dose of 200mEq/day. For serum potassium level < 2.0 with electrocardigraphic changes and/or muscle paralysis, potassium chloride may be administered at a rate up to 40mEq/hour. (This rate is not approved for EMS personnel). Administer at a rate not to exceed 10mEq/hour. Monitor electrolyte, fluid, and acid-base balances. JANUARY 1, 2007

Source: http://www.co.san-joaquin.ca.us/ems/PDF/Policies/5952_KCLInfusion.pdf

Metabolický bulletin 01_1

Metabolic Bulletin January – February 2011 Adherence to Diet and Quality of Life in Patients with Phenylketonuria.3Dietary Treatment of Phenylketonuria: The Effect of Phenylalanine on Reaction Time.4L-Phenylalanine Concentration in Blood of Phenylketonuria Patients: A Modified EnzymeColorimetric Assay Compared with Amino Acid Analysis, Tandem Mass Spectrometry, and HplcMethods.

Agoraphobia

Agoraphobia What is agoraphobia? Agoraphobia is an anxiety disorder. If you have agoraphobia, you avoid going places or doing things because you are afraid you will have no way to escape or will panic and have no help. For example, you might have an intense fear of driving, crossing bridges, or being in shopping malls. You fear the reactions, called panic attacks, that you will have in the

Copyright © 2012-2014 Medical Theses